tranexamic acid has been researched along with Diabetes Mellitus in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| LoŠŤÁk, J | 1 |
| Gallo, J | 1 |
| BalÁŽ, Ľ | 1 |
| ZapletalovÁ, J | 1 |
| Kerros, H | 1 |
| Roule, V | 1 |
| Ivascau, C | 1 |
| Labombarda, F | 1 |
1 trial available for tranexamic acid and Diabetes Mellitus
| Article | Year |
|---|---|
Optimal Route for Tranexamic Acid in Diabetics and Obese Patients Undergoing Primary Total Knee Arthroplasty - a Data from Randomized Study.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgi | 2020 |
1 other study available for tranexamic acid and Diabetes Mellitus
| Article | Year |
|---|---|
Management of May-Hegglin anomaly referred for coronary artery bypass.
Topics: Adult; Anesthetics; Blood Platelets; Cell Size; Coronary Artery Bypass; Diabetes Complications; Diab | 2011 |